Bausch + Lomb launches Infuse Multifocal SiHy daily disposable contact lenses in the US


Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses leverage Bausch + Lomb’s proprietary lens tech to deliver all-day comfort and seamless transitions between near, intermediate, and distance vision for patients with presbyopia.

a woman putting a contact lense into her eye. (Image Credit: AdobeStock/daniiD)

(Image Credit: AdobeStock/daniiD)

Bausch + Lomb announced the United States launch of their Infuse Multifocal silicone hydrogel (SiHy) daily disposable contact lenses. The lenses leverage Bausch + Lomb’s ProBalance Technology and their proprietary 3-Zone Progressive design to deliver all-day comfort and seamless transitions across near, intermediate, and distance vision in the hopes of meeting the dynamic vision needs of patients with presbyopia.1

"Presbyopic patients have unique vision needs due to their age and lifestyle. Our Bausch + Lomb INFUSE Multifocal SiHy contact lenses were designed to directly address the common problems that they experience with multifocal contact lenses, such as contact lens dryness, which nearly 70% of multifocal contact lens wearers report experiencing during lens wear," said Yang Yang, senior vice president, Vision Care, Bausch + Lomb. “With the prevalence of presbyopia estimated to be nearly 80% by age 45-55 in North America, and an increasing aging society in the United States that spends more than nine hours a day on digital devices, we are proud to use our latest science and contact lens technologies to provide eye care professionals and their patients with this new innovative multifocal lens option.”2-4

Made with kalifilcon A, a next generation SiHy daily disposable lens material, the Infuse Mulitifocal lens combines breathability with a low modulus and high moisture, which results in 96% moisture retention for a full 16 hours.5 The lens technology combines ingredients that were found within the Tear Film and Ocular Surface Society’s DEWS II report to maintain ocular surface homeostasis and minimize lens dryness, and Bausch + Lomb’s unique ProBalance Technology releases the moisturizing cocktail throughout lens wear for all-day comfort. Thanks to the unique 3-Zone Progressive design, a survey found that 90% of presbyopic patients reported effortless transitions between tasks throughout the day.6

In addition to rave reviews from study participants, eye care professionals reported success with the Infuse Multifocal SiHy contact lenses: Through a survey, practitioners agreed that the lenses were easy to fit for 99% of patients.7

With daily disposable lenses, sustainability is always in question. Bausch + Lomb’s complimentary contact lens recycling programs addresses that barrier head on: Practitioners and contact lens wearers are both encouraged to recycle their used contact lens materials, such as lenses, blister packs, and top foils. Please visit the ONE by ONE Recycling program page to learn how to participate.

  1. Bausch + Lomb launches Bausch + Lomb INFUSE Multifocal Silicone Hydrogel contact lenses in the United States. Press release. Bausch + Lomb. June 5, 2023. Accessed June 5, 2023.
  2. Zebardast N, Friedman DS, Vitale S. The Prevalence and Demographic Associations of Presenting Near-Vision Impairment Among Adults Living in the United States. Am J Ophthalmol. 2017;174:134-144.
  3. The Administration for Community Living. 2021 Profile of Older Americans. Retrieved from:
  4. The Vision Council. Hindsight 20/20/20: protecting your eyes from digital devices. 2015 Digital Eye Strain Report.
  5. Data on file. Bausch & Lomb Incorporated. Rochester, NY.
  6. Results from a 20-site, 3-week study of Bausch + Lomb INFUSE Multifocal contact lenses on habitual multifocal soft contact lens wearers. 290 subjects completed a lens performance rating survey following the 3-week follow-up visit. Performance was rated using a 7-point agree/disagree scale.
  7. Results from a 20-site, 3-week study of Bausch + Lomb INFUSE® Multifocal contact lenses on habitual multifocal soft contact lens wearers. Eye Care Professionals evaluated fit/performance following the 3-week follow-up visit with survey responses for 292 subjects.
Recent Videos
Visus Therapeutics CEO announces acquisition of ViewPoint Therapeutics to expand on cataract, presbyopia candidate
© 2024 MJH Life Sciences

All rights reserved.